Sino-Swed Pharmaceutical Corporation Report issue

For profit Phase 3
Founded: Beijing China (1982)
Status: Left NME R&D (2012)

Organization Overview

First Clinical Trial
2002
NCT00292279
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2002

Timeline

NOW
  • Now